A
Arthur C. Ouwehand
Researcher at DuPont
Publications - 322
Citations - 23844
Arthur C. Ouwehand is an academic researcher from DuPont. The author has contributed to research in topics: Probiotic & Bifidobacterium. The author has an hindex of 80, co-authored 309 publications receiving 21180 citations. Previous affiliations of Arthur C. Ouwehand include University of Gothenburg & Danisco.
Papers
More filters
Journal ArticleDOI
Consumption of Bifidobacterium lactis Bi-07 by healthy elderly adults enhances phagocytic activity of monocytes and granulocytes
Sujira Maneerat,Markus J. Lehtinen,Caroline E. Childs,Sofia D. Forssten,Esa Alhoniemi,Milin Tiphaine,Parveen Yaqoob,Arthur C. Ouwehand,Robert A. Rastall +8 more
TL;DR: It is shown for the first time that the probiotic Bi-07 may provide health benefits to elderly individuals by improving the phagocytic activity of monocytes and granulocytes and the effects of some probiotics and prebiotics may last longer than in adults.
Journal ArticleDOI
Potential of enterococci isolated from horses.
Andrea Lauková,Monika Pogány Simonová,Viola Strompfová,Igor Štyriak,Arthur C. Ouwehand,Marián Várady +5 more
TL;DR: Enterococci from horses did not bind bovine apotransferrin, and three suitable candidates-the strains of E. faecium EF 412, EF 462 and EF 491 were selected for further detail studies and possibilities to be used as additives.
Journal ArticleDOI
Performance of bifidobacteria in oat-based media.
TL;DR: The strains isolated from the elderly subjects were found to adhere in high levels to immobilised intestinal mucus from elderly, however, their adhesion to colonic tissue was significantly lower than other Bifidobacterium strains isolated.
Journal ArticleDOI
Enzyme catalysed production of sialylated human milk oligosaccharides and galactooligosaccharides by Trypanosoma cruzi trans-sialidase.
Jesper Holck,Dorte Møller Larsen,Malwina Michalak,Haiying Li,Louise Kjaerulff,Finn Kirpekar,Charlotte Held Gotfredsen,Sofia D. Forssten,Arthur C. Ouwehand,Jørn Dalgaard Mikkelsen,Anne S. Meyer +10 more
TL;DR: Proof of the concept of producing 3'-sialyllactose and potentially other sIALylated HMOs as well as sialylated GOS enzymatically by trans-sialidase activity is provided, while at the same time providing valorisation of CGMP, a co-processing product from cheese manufacture.
Patent
Probiotic bacteria for the topical treatment of skin disorders
TL;DR: In this paper, a probiotic bacteria, and/or soluble metabolite of a Probiotic bacteria and cell lysate of Probiotic Bacteria for use in the treatment of a disorder associated with Tight Junction function is described.